Home/Hedge Fund Intelligence/Arrowhead Pharmaceuticals, Inc.
Nasdaq: ARWRStockForm 13F30 Jun 2026

Hedge funds that hold Arrowhead Pharmaceuticals, Inc. Nasdaq: ARWR

CUSIP 04280A100 · who reports it, how much, and how much it matters to them

37 of the 720 hedge fund managers we track reported shares of Arrowhead Pharmaceuticals, Inc. (Nasdaq: ARWR) on Form 13F for 30 June 2026. Between them they reported USD 1.6bn. The largest position belongs to Avoro Capital Advisors, at USD 926m.

Managers reporting it37of 720 we track
Value they reportUSD 1.6bnshares only, 30 Jun 2026
Funds they run616with a file on PPLI.com
Largest positionUSD 926mAvoro Capital Advisors
Typical weight0.0%median share of a manager's book
Heaviest weight8.3%Avoro Capital Advisors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

37 managers, USD 1.6bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Arrowhead Pharmaceuticals, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Avoro Capital Advisors1 fund on PPLI.comUSD 926m8.3%
2Baker Bros. Advisors2 funds on PPLI.comUSD 162m0.8%
3Holocene Advisors2 funds on PPLI.comUSD 90m0.2%
4Summit Partners Public Asset Management14 funds on PPLI.comUSD 68m1.2%
5Two Sigma Investments35 funds on PPLI.comUSD 47m0.0%
6Balyasny Asset Management25 funds on PPLI.comUSD 38m0.0%
7Renaissance Technologies13 funds on PPLI.comUSD 38m0.1%
8D. E. Shaw & Co.15 funds on PPLI.comUSD 35m0.0%
9Millennium Management6 funds on PPLI.comUSD 27m0.0%
10Artisan Partners1 fund on PPLI.comUSD 25m0.0%
11Marshall Wace LLP84 funds on PPLI.comUSD 25m0.0%
12Squarepoint Ops7 funds on PPLI.comUSD 21m0.0%
13Weiss Asset Management5 funds on PPLI.comUSD 11m0.1%
14PFM Health Sciences3 funds on PPLI.comUSD 11m0.9%
15Platinum Investment Management11 funds on PPLI.comUSD 5.3m1.3%
16Jain Global1 fund on PPLI.comUSD 5m0.0%
17Brevan Howard Capital Management39 funds on PPLI.comUSD 4.8m0.0%
18Cormorant Asset Management1 fund on PPLI.comUSD 4.1m0.2%
19Boothbay Fund Management2 funds on PPLI.comUSD 3.4m0.0%
20Edgestream Partners5 funds on PPLI.comUSD 3.2m0.1%
21M28 Capital Management1 fund on PPLI.comUSD 3m6.4%
22Polymer Capital Management (HK)1 fund on PPLI.comUSD 3m0.2%
23Engineers Gate Manager1 fund on PPLI.comUSD 3m0.0%
24Exome Asset Management2 funds on PPLI.comUSD 2.6m1.6%
25Landscape Capital Management4 funds on PPLI.comUSD 2.1m0.1%
26Hudson Bay Capital Management8 funds on PPLI.comUSD 2.1m0.0%
27LMR Partners2 funds on PPLI.comUSD 1.6m0.0%
28Voleon Capital Management13 funds on PPLI.comUSD 1.5m0.0%
29Schonfeld Strategic Advisors30 funds on PPLI.comUSD 749,0000.0%
30Diametric Capital2 funds on PPLI.comUSD 694,0000.1%
31Dark Forest Capital Management2 funds on PPLI.comUSD 679,0000.0%
32Lighthouse Investment Partners190 funds on PPLI.comUSD 611,0000.0%
33Ivyrock Asset Management (HK)1 fund on PPLI.comUSD 571,0000.3%
34CIBC Asset Management69 funds on PPLI.comUSD 353,0000.0%
35Bayforest Capital1 fund on PPLI.comUSD 270,0000.2%
36Persistent Asset Partners10 funds on PPLI.comUSD 39,2880.0%
37Fulcrum Asset Management LLP7 funds on PPLI.comUSD 10,3040.0%
Next: where it matters most
Where it matters most

For Avoro Capital Advisors it is 8.3% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Avoro Capital AdvisorsUSD 926m8.3%
2M28 Capital ManagementUSD 3m6.4%
3Exome Asset ManagementUSD 2.6m1.6%
4Platinum Investment ManagementUSD 5.3m1.3%
5Summit Partners Public Asset ManagementUSD 68m1.2%
6PFM Health SciencesUSD 11m0.9%
7Baker Bros. AdvisorsUSD 162m0.8%
8Ivyrock Asset Management (HK)USD 571,0000.3%
9Bayforest CapitalUSD 270,0000.2%
10Cormorant Asset ManagementUSD 4.1m0.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Arrowhead Pharmaceuticals, Inc.

What is the ticker symbol of Arrowhead Pharmaceuticals, Inc.?

Arrowhead Pharmaceuticals, Inc. trades under the symbol ARWR on the Nasdaq. Its CUSIP, the code used on Form 13F, is 04280A100.

Which hedge funds own Arrowhead Pharmaceuticals, Inc. (Nasdaq: ARWR)?

37 of the 720 hedge fund managers PPLI.com tracks reported Arrowhead Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Avoro Capital Advisors (USD 926m), Baker Bros. Advisors (USD 162m), Holocene Advisors (USD 90m), Summit Partners Public Asset Management (USD 68m) and Two Sigma Investments (USD 47m).

How many hedge funds hold Arrowhead Pharmaceuticals, Inc.?

37 managers in our coverage reported it, and between them they run 616 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Arrowhead Pharmaceuticals, Inc.?

Avoro Capital Advisors, where the position was 8.3% of the reported 13F book at 30 June 2026.

Does this show who is short Arrowhead Pharmaceuticals, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Arrowhead Pharmaceuticals, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.